Stem-Cell Research
New cytokine-dependent AML cell line with novel features established
Published in Gene Therapy Weekly, July 15th, 2004
According to recent research from Germany, "Continuous human leukemia-lymphoma (LL) cell lines represent a rich resource of abundant, accessible and manipulable living cells contributing significantly to a better understanding of the pathophysiology of hematopoietic tumors.
"In particular, classical and molecular cytogenetics have benefitted enormously from the availability of LL cell lines with specific chromosomal abnormalities. Such aberrations may be the portal to the discovery of novel oncogene rearrangements for which positive cell lines provide...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-07-15)
More Articles from Gene Therapy Weekly
- Coronary Artery Bypass Surgery
Overexpressed p53 blocks neointima formation after vein grafting - Neuroscience
Neurotrophic genes offer neuroprotection to Huntington disease models - Oncology
Gene therapy and chemotherapeutic agents help tumors overcome TRAIL resistance - Pulmonary Medicine
The 1-cys peroxiredoxin gene protects murine lungs against hyperoxic injury - Stem Cell Research
Adult stem cells destined for therapeutic use require antigen reduction - Amyotrophic Lateral Sclerosis
Lentiviral delivery of growth factor prolongs the lives of murine ALS models - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
